Global Cell-Free DNA (cf-DNA) Testing Market, 2022 - Cell-Free Fetal DNA Testing Market Is Dominating the Market - Research and Markets
DUBLIN, June 14, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cell-Free DNA (cf-DNA) Testing Global Market - Forecast to 2022" report to their offering.
The cell-free DNA testing global market is segmented based on the type, applications and geography. By type the market is divided into cell-free fetal DNA, circulating cell-free tumour DNA, Donor derived cell-free DNA. By application, the Cell-free DNA testing market is divided into gynecology, oncology, and transplantation. `
Growth in the Asian market is attributed to rising prevalence of diseases related to lifestyle change and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The factors driving the growth of this market are raising number of late pregnancies leading to high incidence rates of babies with chromosomal disorders, increasing number of life threatening cancer and infectious diseases are likely to propel the market. In addition, increasing demand for early detection through non-invasive testing procedures, healthy growth with increase in the number of deals by collaborations and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market.
However, lack of trained health care professionals, ethical issues related to genetic testing, lack of standardization, high cost and non affordability in low- and middle-income countries, unfavourable reimbursement policies and strict legal and regulatory guidelines are hampering the growth of the market. The threats for the Cell-free DNA testing market include the availability of alternative screening methods which will impact the existing market.
The cell-free DNA testing global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced assays to maintain their market shares.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.4 Regulatory Affairs
3.5 Porter's Five Force Analysis
3.6 Process Flow Chart Of Cell-Free Dna Tests
3.7 Patent Trends
3.8 Market Share Analysis (Nipt) By Major Players
3.9 Funding Scenario
3.10 Upcoming Technologies
3.11 Research Use Only Cell-Free Dna Tests
4 Cell-Free Dna Testing Global Market, By Type
4.1 Introduction
4.2 Cell-Free Dna Prenatal Testing Global Market, By Test Type
4.3 Cell-Free Tumour Dna Global Testing Market, By Test Type
4.4 Donor Derived Cell-Free Dna Testing Global Market, By Test Type
5 Cell-Free Dna Testing Global Market, By Application
5.1 Introduction
5.2 Gynecology
5.3 Oncology
5.4 Transplantation
6 Cell-Free Dna Testing Global Market, By Region
7 Company Developments
7.1 Introduction
7.2 Agreements, Partnerships & Collaborations
7.3 Acquisitions
7.4 New Product Launch
7.5 Other Developments
7.6 Approvals
8 Company Profiles
8.1 Berry Genomics Co. Ltd
8.2 Bgi (Bgi Diagnostics)
8.3 Biocept, Inc.
8.4 Caredx, Inc.
8.5 Guardant Health, Inc.
8.6 Illumina, Inc.
8.7 Inivata Limited
8.8 Laboratory Corp. Of America Holdings (Labcorp)
8.9 Lifecodexx Ag
8.10 Natera, Inc.
8.11 Personal Genome Diagnostics
8.12 Quest Diagnostics
8.13 Roche Holdings Ag
8.14 Sequenom, Inc.
8.15 Trovagene, Inc.
For more information visit http://www.researchandmarkets.com/research/32tdbr/cellfree_dna
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article